Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0009450 (
infectious diseases
)
83,438
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Antiviral agents are valuable adjuncts to vaccine in the control of type A
influenza
. Amantadine has been available for many years for prophylaxis and therapy, but there have been concerns about side effects, particularly in the elderly. Thus, the anticipated licensure of rimantadine, an antiviral with the same efficacy as amantadine but with fewer side effects, has been viewed as a major advance. Rimantadine has thus far remained unlicensed, and attention has become focused on antiviral resistance to these drugs, an issue previously recognized but not considered important in decisions concerning drug use. The major implications of antiviral resistance relate to questions of whether there are differences in pathogenicity and transmissibility of resistant
influenza
type A viruses in comparison with sensitive ones. Resistant viruses have not been found to be more virulent than sensitive ones. The extent to which they may be transmitted or perpetuated has not been established. In light of this situation, it is suggested that drug use not be sharply restricted and that recommendations be periodically reviewed as more definitive data become available. As with any
infectious disease
, attempts should be made to limit exposure of uninfected individuals to those infected with the
influenza
A virus, regardless of whether they are receiving an antiviral drug.
...
PMID:Implications of viral resistance to amantadine in control of influenza A. 152 Jul 70
Infection
control, nursing and occupational health at St Mary's Hospital and Marian Villa Home for the Aged collaborated to develop, present and evaluate a successful
influenza
immunization program for patients, residents and staff. The methods used may be applied to any health care facility for a major immunization program. The success of the program can be attributed to the enthusiastic efforts of all three departments and a dedicated task force.
...
PMID:Influenza immunization program in long term care facilities. 152 80
We investigated the possible involvement of oxidative mechanisms in the pathogenesis of
influenza
A/PR8/34 virus infection in mice. As a biochemical marker of oxidative stress, we determined the endogenous concentrations of the antioxidants glutathione and vitamins C and E in their reduced and oxidized forms in the lungs, liver and blood plasma of control and infected animals. Following intranasal infection with 8 to 10 LD50,
influenza
virus was detected in the lungs, but not in the plasma, liver or other organs.
Infection
resulted in a decrease in the total concentration of glutathione and vitamins C and E, whereas no relevant change in the ratio of oxidized to total concentration of antioxidants was observed. Changes in the concentration of hepatic antioxidants were significant in the early stages of the infection. The results suggest that hepatic alterations may be caused indirectly by mechanisms related to the host response to virus infection. The observed general decrease in the antioxidant buffering capacity may reduce the ability of tissues to protect against potential oxidative stress. Such stress can occur during bacterial superinfections, which are common in
influenza
, thereby rendering the host more susceptible to the pathogenic effects of such agents. In addition, reactive oxygen species produced in the lung may inactivate protease inhibitors, resulting in increased protease activity. Using an in vitro system consisting of alpha 1-antiprotease, trypsin and HOCl as the oxidant, we have shown that the infectivity of
influenza
viruses can be increased up to 10,000-fold by proteolytic cleavage of haemagglutinin, leading to activation of the fusogenic properties of this protein.
...
PMID:Alterations in antioxidant defences in lung and liver of mice infected with influenza A virus. 153 Sep 63
Dendritic cells (DC) have a potent antigen-presenting capacity for recruiting resting T cells into immune responses. They also promote expansion of already activated memory T cells. By contrast, macrophages (M phi) are only effective in stimulating memory responses.
Infection
and depletion of DC occur in human immunodeficiency virus (HIV)-infected individuals and recruitment of T cells into primary responses is blocked. Here comparisons between DC and M phi in stimulating secondary T-cell responses in HIV infection were made. Adherent M phi, and DC isolated by a new method, were separated from peripheral blood of patients in different stages of HIV infection and from uninfected controls and added to allogeneic lymphocytes in mixed leucocyte reactions (MLR). Some were pulsed with
influenza
virus or tetanus toxoid and used to stimulate autologous T cells. Responses were measured from uptake of [3H]thymidine in 20 microliters hanging drop cultures. DC, but not M phi, from normal individuals stimulated MLR but both populations stimulated secondary responses to recall antigens. DC from all HIV seropositive individuals caused little or no stimulation of any lymphocyte responses. However, M phi from HIV seropositive asymptomatic individuals and those with persistent generalized lymphadenopathy stimulated responses to recall antigens. There was no stimulation using cells from acquired immune deficiency syndrome (AIDS) patients. Blocked DC but not M phi function may underlie progressive immunological non-responsiveness in HIV infection. Without recruitment of resting T cells, loss of memory T cells may be cumulative; failure of secondary activation (e.g. by M phi) would lead to lost T-cell activity. Identification and circumvention of the defect in DC could offer new therapeutic approaches.
...
PMID:Antigen-presentation by macrophages but not by dendritic cells in human immunodeficiency virus (HIV) infection. 153 9
Secretory antibodies in mucosal surfaces are known to play an essential role in protection against various
infectious diseases
. To enhance the production of such antibodies,
influenza
HA vaccine was inoculated intranasally into rabbits, together with cholera toxin B subunit (CTB) which is known to augment antibody response to an unrelated antigen. This combination resulted in high levels of serum IgG antibody responses against HA and CTB molecules, 3-4 weeks after inoculation, compared with the inoculation of HA vaccine alone. The adjuvant mechanism for CTB was studied by using Ussing chambers, in which nasal mucosa from rabbits were mounted. CTB was found to enhance the transepithelial flux of HA vaccine, from the mucosal side (lumen) into the serosal side (lamina propria), indicating that the permeability of the membrane was changed by CTB. Moreover, to achieve effective flux of HA vaccines, some interactions between the vaccine and CTB across the membrane were found, which may effect the effectiveness of the vaccine formulation. The results suggest that one of the mechanisms by which CTB enhances the production of mucosal antibody response is to enhance the transepithelial influx of vaccine into the nasal mucosa, where the cells involved in the antibody production are located. CTB may be used as a potent adjuvant to induce antibody response, by nasal vaccination, against pathogens impinging on mucosal surfaces.
...
PMID:Stimulation of the transepithelial flux of influenza HA vaccine by cholera toxin B subunit. 153 62
Symptoms of infection in the elderly may be absent, vague or atypical.
Infection
should be suspected when an elderly patient presents with a decline in well-being or with non-specific symptoms such as falls, dizziness, confusion, anorexia or weakness. Common infections include bacterial pneumonia, urinary tract infection, intra-abdominal infections, gram-negative bacteremia and infection of decubitus ulcers. Antibiotic therapy is not recommended for asymptomatic bacteriuria or locally infected decubitus ulcers. Drug dosages should be adjusted for the age-associated decline in renal function and for hepatic or renal insufficiency. The trend in antibiotic therapy is evolving toward the use of third-generation cephalosporins instead of aminoglycosides to avoid the side effects of nephrotoxicity and ototoxicity. Pneumococcal,
influenza
and tetanus/diphtheria immunizations help prevent morbidity and mortality.
...
PMID:Common infections in the elderly. 848 May 62
The Committee on
Infectious Diseases
of the American Academy of Pediatrics, and the Advisory Committee on Immunization Practices of the Center for Disease Control for many years have recommended the routine use of
influenza
vaccine in various hemoglobinopathies including sickle cell disease. This recommendation, however, has not been included in the patient care protocols of the Comprehensive Sickle Cell Centers program of NIHLB. Most clinicians have not used yearly
influenza
vaccine for their patients with sickle cell disease. This article reports a case of a 5-year-old boy with sickle cell disease who had not received
influenza
vaccine. He developed pneumonitis and acute myositis during a serologically confirmed
influenza
B virus infection. The incapacitating and protracted course of his illness presented diagnostic and management problems. His case strongly supports the recommendation of the two
infectious disease
committees.
...
PMID:Sickle cell disease with complicated influenza B virus infection. 160 65
Our understanding of the host defense and pathogenesis of
influenza
has come from parallel studies in animal models and humans.
Infection
is initiated by deposition of
influenza
particles on either the upper respiratory tract epithelium or directly into the alveoli, with the former method having a lethal dose several orders of magnitude greater than the latter. The virus attaches to its cellular receptor by its hemagglutinin (HA); if this step is blocked by specific antibody, infection does not take place. The major role of antibody is in the prevention of disease. Even though serum antibody (primarily antihemagglutinin, but also antineuraminidase) has been known for decades to prevent viral pneumonia, it has only more recently been shown that passive administration of anti-
influenza
serum to virgin mice prevents pneumonia, but not rhinotracheitis. Further, intravenously administered anti-
influenza
IgA has been shown to be specifically transported into the nasal secretions and protect the murine nasopharynx against
influenza
infection. Whereas antibody is clearly required for protection against
influenza
, cytotoxic T-lymphocyte (CTL) activity is both necessary and sufficient for recovery from
influenza
. This was best shown in studies using nude (athymic) mice.
Influenza
-infected nude mice shed virus from their lungs indefinitely. Adoptive transfer of anti-
influenza
CTLs to
influenza
-infected nude mice will clear the virus from their lungs, whereas administration of anti-
influenza
antibody will lead to a cessation of viral shedding only as long as antibody is present.
Influenza
in aging presents a serious clinical problem. Recent studies suggest that the age-related decrease in anti-
influenza
CTL activity causes both prolonged viral shedding and increased viral spread through the respiratory tract.
...
PMID:Influenza: pathogenesis and host defense. 160 66
Comparative studies on the local IgA, and circulating IgG subclass antibody responses of mice to A/Sichuan/2/87 (H3N2)
influenza
virus surface antigens administered with different carrier or delivery systems by the parenteral route, were carried out. The results obtained were compared with the responses observed following live
influenza
virus infection, and the protection afforded to these animals by these various preparations determined.
Infection
with live virus elicited early and high levels of protection against homologous virus challenge and this correlated with both local IgA and circulating IgG2a antibody levels. When incorporated into immunostimulating complexes (ISCOMS), A/Sichuan surface antigens promoted high levels of local IgA and circulating IgG1 antibody, and achieved a more rapid and more solid immunity against homologous virus challenge infection, than that elicited by the same surface antigens administered alone or together with Freund's complete adjuvant or alhydrogel.
...
PMID:The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMS, with FCA, ALH or as infectious virus. 164 61
With reference to the fact that so far there have been no comprehensive investigations of the occurrence of outbreak of Spanish
influenza
in the area of the city of Zagreb, in this study, on the basis of the public records and documents as well as the report given by the Municipal Authorities of the General Administration of the free and royal capital Zagreb, a retrospective analysis of the outbreak of Spanish
influenza
in Zagreb is given. Since the official reports of the evidence of
infectious diseases
did not give exact insight in the epidemiological events in 1918, a detailed analysis of the books of autopsy records of the Public health institutions has been done. The aim was to determine the very beginning of Spanish
influenza
in the city of Zagreb in 1918. It has been found that the first patients suffering from Spanish
influenza
appeared in July 1918. In the period from 1 September to the end of 1918, a total of 861 persons died because of Spanish
influenza
and complications caused by pneumonia. The analyzed autopsy records have demonstrated that the usual complication following
influenza
was pneumonia characterized by hemorrhagic edema. Knowing the tendency of
influenza
outbreak to recur at regular intervals more eminent onset of the pandemic type similar to that of 1918 may be expected.
...
PMID:[Spanish influenza as a cause of death in Zagreb in 1918]. 166 21
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>